GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 antibody with rbd

Analyse Crystal structure of SARS-cov-2 antibody with rbd in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7BWJ
Type
protein
Length
636 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike protein S1; Antibody light chain; Antibody heavy chain
UniProt
P0DTC2
Ligands
NAG
Pockets
5 · best druggability 0.64

Structure

x-ray diffraction · 3 distinct chains · 9% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ESpike protein S1protein19417% helix, 29% strandP0DTC2
LAntibody light chainprotein2137% helix, 49% strand—
HAntibody heavy chainprotein2295% helix, 49% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16400.640.7474empty
21530.450.7623empty
31760.440.7428empty
41430.410.7424empty
5900.380.7622empty

Interfaces

3 interfaces between chains.

  • L–H · 1897 Ų buried · 17 hydrogen bonds · protein-protein
  • E–H · 520 Ų buried · 6 hydrogen bonds · protein-protein
  • E–L · 163 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7BWJ · crystal structure of SARS-CoV-2 antibody with RBD · the same entry in another collection · chain E against E, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.